The 2026–2027 budget is in line with the priorities established by the Quebec Life Sciences Strategy as well…
Feldan Therapeutics (“Feldan”), a clinical-stage biotech company specializing in the development of therapies based on…
CSL Seqirus will supply millions of doses of adjuvanted cell-based vaccine to support Canadians, in the event…
BIOQuébec publishes a position statement on the evolution of procurement practices in…
Génome Québec is proud to announce funding for 12 new innovative research projects through its…
Aramis Biotechnologies Inc. (“Aramis”), a Canadian company pioneering and a global leader in…
We use cookies to improve your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
Privacy Policy






